SCIENCE: An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.

Speech sensitive to treatment response

J Neurol. 2015 May;262(5):1344-53. doi: 10.1007/s00415-015-7719-2

Related Post

  • Posted on 30 August, 2021
    Stereotypical depictions of speech in cannabis users often suggest slow, laboured output, yet objective evidence supporting this assumption is extremely...
    • Posted on 14 December, 2020
      Speech production relies on motor control and cognitive processing and is linked to cerebellar function. In diseases where the cerebellum...
      • Posted on 12 June, 2020
        PurposeApproximately 30% of adults over the age of 50 years present with altered vocal function. Our understanding of how these...